The Inspire Sleep Apnea Implant is a medical device that’s implanted into the body for the treatment of snoring and obstructive anti snoring (OSA) syndrome.
Obstructive ANTI SNORING Syndrome
Obstructive sleep apnea syndrome is a disease caused by relapsing episodes of sleep apnea. This is usually a condition where breathing stops for more than 10 seconds, where oxygen saturation in the blood is reduced by a lot more than 4%.
OSA syndrome occurs while asleep, when the muscles of upper airways relax, evoking the obstruction of the respiratory tract. This leads to deterioration of blood oxygenation and provokes short unconscious wake-up episodes throughout the night. An unhealthy pattern of sleep places stress on the body, causing increased blood circulation pressure and development of severe diseases. The diseases due to OSA could be physical, such as for example hypertension, myocardium infarction and stroke. They might also be mental, including depression, chronic fatigue syndrome, lack of memory and concentration.
Before any treatment, a sleep study or a polysomnography is necessary. The polysomnography calculates the apnea index, that is the frequency of apnea episodes during one hour of sleep and determines the severity of the disease. The apnea index is considered significant if you can find more than 20 apnea episodes per hour, whatever the presence or lack of clinical symptoms.
The gold standard of treatment for OSA syndrome is CPAP-therapy. However, CPAP therapy is not for everyone as many folks think it is uncomfortable to sleep with the mask on the facial skin and the device itself can be loud, especially since it commonly sits near the head. Only 25% of patients may use CPAP-therapy for an extended period of time.
Therefore, recently Inspire Medical Systems Inc. has come up with a very effective solution with the Inspire Sleep Apnea Implant.
How The Inspire Sleep Apnea Implant Works
The Inspire Sleep Apnea Implant is a battery operated device that promotes electrostimulation of the sublingual nerve. The battery life is approximately 10 years.
The main unit of this device is placed beneath the skin, on leading right side of the chest also it monitors the phase of breathing. The other electrode is implanted for stimulation of the sublingual nerve, which creates muscle tension. This opens top of the airways and allows the tongue to stick out, and helps maintain the airways open during sleep.
As well as the two electrodes, this device also contains a handy small remote switch, that actually turns on the device before sleep and switches it off once awake. ufabet This disables the electrodes from disturbing the processes of communication and eating during the active phase of your day, when a person needs physiological narrowing of the larynx and tongue movements for these procedures.
The patient may feel light involuntary contractions of the larynx, or tongue movements during initial usage of these devices. These movements usually do not cause pain, instead only a minor discomfort. These unpleasant effects disappear following the first few uses of these devices.
Generally, the implant should be checked one or two 2 times per year. However, according to the situation, an Inspire therapy-trained doctor may consult patients more or less often.
The Inspire ANTI SNORING Implant is only ideal for:
Patients who are a lot more than 22 years old.
Patients who’ve been diagnosed with moderate or severe obstructive sleep apnea syndrome.
Patients with an apnea index in the range of 20 to 65.
Patients who are not comfortable with using CPAP therapy or didn’t have the desired effect.
Patients with a body mass index of less than 32.
Body mass index (BMI) = weight (kg) / height^2 (m2).
An individual with a weight of 80 kg and a height of 170 cm has
BMI = 80kg / (1.7m ^ 2) = 80 / 2.89 = 27.68 kg/ m2
The Inspire Sleep Apnea Implant could potentially replace CPAP therapy as ‘the gold standard’ of treatment for obstructive sleep apnea syndrome. A report by Dr. Ryan J. et al. shows that after implantation of the Inspire Sleep Apnea Implant, snoring is greatly decreased. A share of “no” or “soft” snoring changed from 22% at start of the treatment to 88% at 12 months and 91% at two years after the treatment. Also, the apnea index was reduced from 31 to 14. 82% of the patients in the analysis reported a nightly use of this therapy for five years. Therefore, it is evident that this method is impressive and simple to use!